BT-L-CsA-302-DLT BOSTON-3
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
BREATH Therapeutics
Start Date
September 4, 2020
End Date
September 30, 2026
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
BREATH Therapeutics
Start Date
September 4, 2020
End Date
September 30, 2026